JAB-23000

N/A

Report date: 2022/03/23 17:36:46
NME

Base Information

Drug NameJAB-23000
Drug Alias NameJAB-23000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12V inhibitors
TargetsKRAS G12V
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJacobio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A